US Stocks Update | Moderna (MRNA.US) Rises Over 7% on Positive Data for Two New mRNA Vaccines

Stock News
2025/10/20

According to information, on Monday, Moderna (MRNA.US) shares surged, rising over 7% to $27.85 by the time of reporting. The company presented the latest data from its mRNA vaccine pipeline at the IDWeek 2025 conference, including clinical results for the seasonal flu vaccine mRNA-1010 and the combination vaccine mRNA-1018. The data showed that both vaccines elicited rapid and robust immune responses in adult subjects, with no significant safety issues observed.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10